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Background: Only a minority of patients with chronic obstructive pulmonary disease (COPD)
have access to pulmonary rehabilitation (PR). Home-based solutions such as telehealthcare,
have been used in efforts to make PR more available. The aim of this systematic review was
to investigate the effects of telehealthcare on physical activity level, physical capacity and
dyspnea in patients with COPD, and to describe the interventions used.
Methods: Randomized controlled trials were identified through database searches, reference
lists and included authors. Articles were reviewed based on eligibility criteria by three authors.
Risk of bias was assessed by two authors. Standardized mean differences (SMD) or mean differ-
ences (MD) with 95% CI were calculated. Forest plots were used to present data visually.
Results: Nine studies (982 patients) were included. For physical activity level, there was a sig-
nificant effect favoring telehealthcare (MD, 64.7 min; 95% CI, 54.4e74.9). No difference be-
tween groups was found for physical capacity (MD, 1.3 m; 95% CI, 8.1e5.5) and dyspnea
(SMD, 0.088; 95% CI, 0.056e0.233). Telehealthcare was promoted through phone calls, web-
sites or mobile phones, often combined with education and/or exercise training. Comparators
were ordinary care, exercise training and/or education.
Conclusions: The use of telehealthcare may lead to improvements in physical activity level,t; ADL, activities of daily living; C, comparator; CI, confidence interval; COPD, chronic obstructive
spiratory questionnaire, dyspnea subscale; ESWT, endurance shuttle walk test; FEV1, forced expi-
capacity; ITT, incremental treadmill test; MD, mean difference; MRC, Medical Research Council; PR,
ized controlled trial; SMD, standardized mean difference; SOBQ, shortness of breath questionnaire;
tion: An abstract for this study has been accepted for presentation at the ERS International Congress
486 80 42.
se (S. Lundell).
4.10.008
hts reserved.
12 S. Lundell et al.although the results should be interpreted with caution given the heterogeneity in studies. This
is an important area of research and further studies of the effect of telehealthcare for patients
with COPD would be beneficial.
Registration: In PROSPERO 2012: CRD42012003294. Study protocol: http://www.crd.york.ac.
uk/PROSPEROFILES/3294_PROTOCOL_20121016.pdf.
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Decreased physical capacity and dyspnea are common
symptoms in patients with chronic obstructive pulmonary
disease (COPD) [1]. They also show a reduced level of
physical activity compared to healthy controls [2]. Since it
has emerged that reduced physical activity levels increases
the risk for all-cause death in patients with COPD [3], it is
essential to find ways to increase their physical activity
levels.
Pulmonary rehabilitation (PR) including exercise training
is proven to have positive effects on physical capacity,
quality of life and health status among patients with COPD
[4e6]. However, the effect on physical activity level after
the rehabilitation period is inconsistent [6e8]. Further-
more, only a limited number of patients with COPD have
access to PR [9e12].
Since transportation has been reported as the most
common barrier to participation in PR [12,13], home-based
solutions could be used to make PR more available. Tele-
healthcare is one possible option that has gained in interest
lately [6]. Patients with COPD have reported counseling via
telephone as valuable and an aid in developing strategiesfor behavioral changes and increasing motivation to main-
tain those changes [14].
In this systematic review, we have defined tele-
healthcare as: “the use of electronic information and
communications technologies to provide and support health
care when distance separates the participants” [15]. In
telehealthcare, the following criteria have been defined
[16]:
 The information (delivery of health services) is trans-
mitted electronically over a distance
 The information can be, for example, voice, sounds,
video, pictures or text
 The transmission can be asynchronous (store-and-for-
ward applications) or synchronous (e.g. two-way video
consultations)
There is moderate evidence that the use of tele-
healthcare for patients with COPD increases quality of life
and decreases hospital admissions and emergency depart-
ment visits compared to ordinary care [17,18]. The effect
on mortality and patient satisfaction is inconsistent [17,18].
Home-based telehealthcare for patients with chronic dis-
eases also tends to reduce health care costs [19]. In
Telehealthcare in COPD 13previous systematic reviews, the interventions in the
included studies have varied considerably.
To our knowledge, there has not been any previous
systematic evaluation of the effect of telehealthcare on
physical activity level, physical capacity or dyspnea in pa-
tients with COPD.
The aim of this systematic review and meta-analysis was
to investigate the effects of home-based telehealthcare on
physical activity level, physical capacity and dyspnea in
patients with COPD, as well as to describe how these tel-
ehealthcare interventions have been designed.
Materials and methods
The methodology was in accordance with the Preferred
Reporting Items for Systematic reviews and Meta-Analyses
(PRISMA) [20]. The review was registered in PROSPERO
2012: CRD42012003294. The study protocol is available at
http://www.crd.york.ac.uk/PROSPEROFILES/3294_
PROTOCOL_20121016.pdf.
Since more randomized controlled trials (RCTs) than
expected were found, two changes from the protocol have
been made: only RCT studies were included and a meta-
analysis was performed.
Eligibility criteria
Peer-reviewed RCTs with available full text, published in
English were included. There was no restriction in publi-
cation year.
The studies had to meet the following criteria to be
included:
 Participants: 40 years, diagnosed with COPD according
to Global Initiative for Chronic Obstructive Lung Disease
(GOLD) [21], the European Respiratory Society [22], the
American Thoracic Society [23,24], or the British
Thoracic Society [25]. In studies addressing several di-
agnoses, the results for patients with COPD had to be
separately evaluated.
 Interventions: The major part (in length of time or
number of contacts) could be classified as home-based
telehealthcare. Some kind of feedback, motivational
element, or counseling had to be provided to the patient
through telehealthcare at least three times during the
first three months.
 Comparator: Any kind of comparator.
 Outcome measures: Physical activity level (objectively
or questionnaires), physical capacity (objectively), or
dyspnea (questionnaires or scales) had been measured
before and after intervention and (when applicable) at
follow-up.Search strategy and risk of bias
Studies were identified through searches (inception to
August 30, 2013) in the Cochrane Central Register of
Controlled Trials (CENTRAL), PubMed, CINAHL, AMED, Psy-
cINFO, Web of Science, Scopus and PEDro. To increase
sensitivity a broad search strategy (Appendix A1eA3) wasdeveloped by the authors and supported by the search co-
ordinators of the Cochrane Airways Group. For included
studies, the “related citations” function in PubMed was
used, reference lists were searched, and authors were
asked for knowledge of additional articles.
At the start, one author (SL) screened all titles and
excluded articles that were obviously irrelevant. There-
after, three authors (SL, KW and A˚H) used a standardized
form based on eligibility criteria to independently review
abstracts and exclude irrelevant articles. Finally, the same
three authors independently reviewed the full texts, and
articles not meeting eligibility criteria were excluded.
Possible disagreement during the review of full texts was
solved by a majority decision.
Data was extracted using a standardized form based on
the Cochrane checklist of items to consider in data
extraction [26]. Additionally, items to identify multiple
reports from the same study [26] were extracted. Authors
of the included studies were contacted by email to clarify
any unclear information, and to obtain data for the meta-
analysis, if needed.
The Cochrane risk of bias tool [26] was used to assess risk
of bias. Each domain was rated as “low risk”, “high risk” or
“unclear risk” independently by two authors (SL and BR) in
an unblinded manner. If consensus could not be reached, a
third researcher (KW) was involved, and a majority decision
was made.Data analysis
Data was combined using Comprehensive Meta-Analysis
(CMA) software by two authors (AN and SL). I2 statistics
was used to examine heterogeneity amongst individual
studies. For analyses with I2 > 60% outliers were excluded
from the meta-analysis due to heterogeneity (the study
with the most outlying result first), until I2 < 60%, as
recommended [26]. Following strategies were also used to
decrease the impact of heterogeneity [26]: effect mea-
sure was changed to standardized mean difference (SMD)
for analyses with different measurements, sensitivity
analyses were performed and presented and random-
effects model was used if I2 > 30%, otherwise, fixed-
effects model was applied. For the study with multiple
intervention groups, the comparator group was divided as
recommended [26]. Differences were expressed as SMD or
mean difference (MD), with corresponding 95% confidence
intervals (CI). Data were synthesized into forest plots,
and publication bias was assessed statistically using
Egger’s test. P < 0.05 was considered statistically
significant.Results
The broad search strategy used in this systematic review
resulted in 15,574 potentially relevant articles. A total of
597 abstracts and 132 full texts were chosen for review and
nine studies met inclusion criteria [27e35] (Fig. 1). The first
agreement between assessors in the decision of inclusion
and exclusion of studies was 91%. After discussion, agree-
ment was 100%.
Figure 1 Flow chart of study selection process. Abbreviations: COPD Z chronic obstructive pulmonary disease;
THC Z telehealthcare.
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Characteristics of the included studies are presented in
Table 1.
The included studies analyzed a total of 982 patients
(34% women) with COPD. The mean forced expiratory vol-
ume in 1 s (FEV1) in % of the predicted value presented
ranged from 34 to 56 [28,30e34], in other words, moderate
to severe COPD [21]. The inclusion and exclusion criteria
used in the included studies are presented in Appendix B.
All studies were judged to have a high risk of bias in at
least two domains (Table 2 and Appendix C). Six studies
presented approved randomization procedures[27,29,31,32,34,35], and five presented allocation
concealment [30e32,34,35]. No study reported blinding of
participants and personnel, but four studies reported
blinding of outcome assessors [27,29,30,34]. Five studies
included all participants (also dropouts) in analyses
[27,30e32,34]. Only one study presented all outcomes that
were pre-specified in the registration [35]. One study
seemed to be free from other risk of bias [34]. No power
analyses were presented in five studies [28e30,32,33], two
studies did not reach power [27,31], and one study recal-
culated power during the study [35]. There was an uneven
distribution between men and women in two studies [29,32]
and differences between groups at baseline in one study
Table 1 Characteristics of the included studies.
Study Participants Telehealthcare group (THC) Comparator
group (C)
Outcomes Study design Results
Sample size Age (years) FEV1 (liter/%
predicted)
Bourbeau, 2003
[27]. Canada
191 patients (45%
women), 96 in
THC, 95 in C.
THC:
69.46.5
THC: 1.000.33/
e
Telehealthcare: Weekly phone
calls with follow-up of education
for 8 weeks. Then monthly phone
calls until 12 months.
Ordinary care Physical activity
level: Not
reported
RCT 26 dropoutsa (10
THC, 16 C e
included in
analyses).
C:
69.67.4
C: 0.980.31/e Case manager available for advice
by telephone.
Physical
capacity: 6MWT
12 months No changes were
seen within or
between groups
for 6MWT.
Other: 1-hour self-management
education per week for 7-8 weeks.
Training at home (1 supervised
session) 3 times/week, week 7 e
month 12.
Dyspnea: Not
reported
Carrieri-
Kohlman,
1996 [28].
United States
of America
51 patients (51%
women), 24 in
THC, 27 in C.
THC: 687b THC:
0.920.25b/
4011b
Telehealthcare: Weekly phone
calls with reinforcement for
walking and dyspnea control for 8
weeks.
Home walking as
THC. Weekly
phone calls for 8
weeks, about
adherence to
home walking.
Physical activity
level: Not
reported
RCT 1 dropout (from
C e not included
in analyses).
C: 669b C: 0.910.24b/
3610b
Other: Home walking 4 times/week
for 8 weeks.
12 coached
treadmill
exercise sessions
pre-
intervention.
Physical
capacity: 6MWT
8 weeks No changes were
seen within or
between groups
for 6MWT or
dyspnea.
12 coached treadmill exercise
sessions pre-intervention
Dyspnea: CRQ-D,
Baseline/
transitional
dyspnea index,
Visual analogue
scale (during
exercise),
dyspnea indexc
Dyspnea index
decreased
significantly in
both groups. No
difference
between groups.
Garcia-Aymerich,
2007 [29].
Spain
113 patients (14%
women), 44 in
THC, 69 in C.
THC:
7210d
THC: 1.2 (0.8
e1.4)d/e
Telehealthcare: Weekly phone
calls with reinforcing self-
management strategies at month 1,
one phone call at months 3 and 9.
Ordinary care Physical activity
level: Questions
about physical
activity and
regular physical
activity
RCT 51 dropouts (23
from THC, 28
from C e not
included in
analyses).
(continued on next page)
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Table 1 (continued )
Study Participants Telehealthcare group (THC) Comparator
group (C)
Outcomes Study design Results
Sample size Age (years) FEV1 (liter/%
predicted)
C: 739d C: 1.0 (0.8
e1.5)d/e
Access to nurse through web-based
call center.
Physical
capacity: Not
reported
12 months No group
difference in
either physical
activity or
regular physical
activity at 12
months.
Other: Assessment at discharge. 2
hours self-management education.
Individual care plan. One home
visit.
Dyspnea: MRC
Dyspnea scale
No change in
dyspnea within
or between
groups.
Maltais, 2008
[34]. Canada
252 patients (44%
women), 126 in
THC1, 126 in
THC2.
THC1:
669
THC1:
1.130.34/
4613
Telehealthcare: Weekly phone
calls with reinforcement of exercise
training for 8 weeks, phone calls
every 2 months during months 3
e12.
Supervised
training 3 times/
week for 8
weeks.
Encouraged to
keep exercising
at home 3 times/
week during
months 3-12.
Phone call every
2 months during
months 3-12.
Reinforcement of
exercise training.
Physical activity
level: Not
reported
RCT 36 dropouts (19
from THC1, 17
from C e
included in
analyses).
THC2:
669
THC2:
1.080.39/
4313
Case manager available by
telephone.
Case manager
available by
telephone for
advice.
Physical
capacity: 6MWT,
cycling
endurance test
12 months No within- or
between-group
changes in 6MWT.
Other: Training at home 3 times/
week for 8 weeks.
Pre-intervention
self-
management
education: 2
lessons/week for
4 weeks.
Dyspnea: CRQ-D Improvement in
both groups in
cycling
endurance, no
group difference.
Encouraged to keep exercising at
home 3 times/week during months
4e12.
Improvements in
both groups in
dyspnea. No
group difference.
16
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Pre-intervention self-management
education: 2 lessons/week for 4
weeks.
Nguyen, 2009
[30]. United
States of
America
17 patients (65%
women), 8 in
THC, 9 in C.
THC: 729 THC:
e/46.718.7
Telehealthcare: Daily mobile
phone reminders to submit
information about symptoms
(dyspnea, sputum, cough) and
exercise (mode, duration,
dyspnea).
Individualized
exercise program
3-5 times/week,
strategies for
self-care,
pedometer. Daily
reminders to
submit
information
about symptoms
and exercise,
standard weekly
message saying
thanks for
entering
information.
Physical activity
level: Free-living
ambulatory
physical activity
measured with
accelerometer
RCT, pilot study No dropouts. No
significant
within-group
changes in
physical activity
level. C had an
increase in steps
per day
compared to
THC, which
decreased. C
increased more
than THC at time
in moderate to
high intensity
exercise and
peak
performance
(average steps/
min of the best
30 minutes of the
day). No change
in inactive time
C: 6412 C: e/34.415 Weekly reinforcement feedback by
short text messages or telephone.
Physical
capacity: 6MWT
and incremental
cycle ergometer
test
6 months No changes for
6MWT and
incremental
cycle ergometer
test.
Contacted by nurse in case of
worsening of symptoms.
Other: Individualized exercise
program 3e5 times/week,
strategies for self-care, pedometer.
Dyspnea: Not
reported
Nguyen, 2013
[31]. United
States of
America
125 patients (46%
women), 43 in
THC1, 41 in THC2
and 41 in C.
THC1:
68.511
THC1:
e/53.320.4
THC1. THC2. One home visit at
start. Monthly
face-to-face
education
unrelated to lung
disease.
Physical activity
level: Questions
about frequency
and duration of
endurance and
strengthening
exercises for a
typical week
during the last
month.
RCT 17 dropouts (5
from THC1, 6
from THC2 and 6
from C e
included in
analyses).
(continued on next page)
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Table 1 (continued )
Study Participants Telehealthcare group (THC) Comparator
group (C)
Outcomes Study design Results
Sample size Age (years) FEV1 (liter/%
predicted)
THC2:
68.29.9
THC2:
e/50.618.2
Telehealthcare:
Individualized
web-based
education, self-
management,
exercise and
activity plan.
Weekly (first
month) and
biweekly e-mail
with
reinforcement
and feedback.
Monthly live chat
sessions and
bulletin boards
for six months.
Reporting of
symptoms
(dyspnea cough,
sputum),
exercise (mode,
duration,
dyspnea) and
goal-setting over
internet. Nurse
alerted in case of
worsening of
symptoms.
Telehealthcare:
Weekly (first
month) and
biweekly phone
calls with
reinforcement,
feedback and
goal-setting.
Biweekly phone
calls with general
health
information.
Physical
capacity: 6MWT,
ITT, arm
endurance
12 months All groups
improved in
duration and
frequency of
endurance
exercise and
frequency of
strength
exercise.
C:
69.38.0
C: e/49.419.8 Other: One home
visit at start
Other:
Individualized
education, self-
management,
exercise and
activity plan on
paper.
Dyspnea: CRQ-D,
Borg scale during
and after 6MWT
and ITT
THC1 and THC2
improved more in
duration of
endurance
exercise and
frequency of
strengthening
exercise than C.
Monthly face-to-
face meetings at
All groups
improved in
18
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medical centers
for six months.
Weekly reporting
of symptoms and
exercise in paper
diaries
6MWT. No within-
group change at
ITT. No
difference
between groups
at 6MWT or ITT.
THC1 and THC2
performed more
arm lifts than C.
Improvement of
CRQ-D for THC1.
No difference
between groups
at CRQ-D or Borg
scale.
Nield, 2012 [32].
United States
of America
22 patients (no
women), 11 in
THC, 11 in C.
THC: 648 THC: e/5516 Telehealthcare: Weekly sessions 15
e30 min via Skype with feedback on
pursed lips breathing and use in
daily life.
10 min face-to-
face pursed lips
breathing
education. Daily
practice of
pursed lips
breathing at
home.
P sical activity
le el: Not
re orted
RCT, feasibility
study
6 dropouts (2
from THC and 4
from C e
included in
analyses).
C: 655 C: e/5612 Other: Starting with 10 min face-
to-face pursed lips breathing
education. Daily practice of pursed
lips breathing at home.
P sical
ca acity: 6MWT
4 weeks 6MWT improved
in both groups,
no difference
between groups.
D pnea: SOBQ,
V al analogue
sc le, Borg scale
b ore and after
6M T
Follow-up at 12
weeks
No within- or
between-group
differences in
dyspnea.
Oh, 2003 [33].
South Korea
34 patients, only
23 patients
presented (39%
women), 15 in
THC, 8 in C.
THC:
64.87.8d
THC:
e/42.115.1d
Telehealthcare: Telephone calls
with discussion of problems and
concerns 2 times/week.
One education
session
P sical activity
le el: Not
re orted
RCT 11 dropouts (4
from THC, 7 from
C e not included
in analyses).
C:
66.812.3d
C:e/44.917.8d Other: One education session,
inspiratory muscle training 5 times/
day, exercise training, relaxation
twice daily.
P sical
ca acity: 6MWT
8 weeks Distance at
6MWT improved
in THC and THC
improved more in
6MWT
(continued on next page)
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Table 1 (continued )
Study Participants Telehealthcare group (THC) Comparator
group (C)
Outcomes Study design Results
Sample size Age (years) FEV1 (liter/%
predicted)
Dyspnea: CRQ-D,
Borg scale after
6MWT
and dyspnea
measured with
Borg scale than
C. No within or
between group
differences in
CRQ-D.
Waterhouse,
2010 [35].
United
Kingdom
240 patientsb
(48% women), 55
in THC1b, 64 in
THC2b, 56 in C1b,
65 in C2b.
THC1:
67.88.8b
THC1: 1.10.5b/
e
Telehealthcare: Monthly phone
calls with encouragement to
exercise for 6 months, then at
months 9, 12, and 15 months.
Ordinary care. Physical activity
level: Not
reported
RCT 27 dropouts from
baseline (8 from
THC1, 8 from
THC2, 7 from C1,
4 from C2), 105
dropouts in total
from pre-
intervention (30
from THC1, 24
from THC2, 20
from C1, 31 from
C2). Dropouts not
included in the
analyses.
THC2:
69.27.8b
THC2: 1.10.5b/
e
Other: Pre-rehabilitation
containing community-based versus
hospital-based education and
exercise.
Pre-
rehabilitation
containing
community-
based versus
hospital-based
education and
exercise.
Physical
capacity: ESWT
18 months No changes
within-group or
between-group
for ESWT or CRQ-
D.
C1:
69.77.8b
C1: 1.10.4b/e Dyspnea: CRQ-D
C2:
697.3b
C2: 1.20.5b/e
Abbreviations: 6MWT Z 6-minute walk test; C Z comparator; CRQ-D Z chronic respiratory questionnaire, dyspnea subscale; ESWT Z endurance shuttle walk test; FEV1 Z forced
expiratory volume in one second; ITTZ incremental treadmill test; MRCZ medical research council; RCTZ randomized controlled trial; SOBQZ shortness of breath questionnaire; THC
Z telehealthcare
a Dropout is defined as subjects who for any reason, fail to complete the trial.
b Before pre-intervention.
c Dyspnea after 6MWT divided with the distance walked.
d Dropouts not presented.
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Table 2 Risk of bias in the included studies.
Study Random
sequence
generation
Allocation
concealment
Blinding of
participants and
personnel
Blinding of
outcome
assessment
Incomplete
outcome
data
Selective
reporting
Other
sources of
bias
Domains with
low risk of
bias
Bourbeau,
2003 [27].
☺ ? ☹ ☺ ☺ ☹ ☹ 3/7
Carrieri-
Kohlman,
1996 [28].
? ? ? ? ☹ ☹ ☹ 0/7
Garcia-
Aymerich,
2007 [29].
☺ ? ? ☺ ☹ ? ☹ 2/7
Maltais, 2008
[34].
☺ ☺ ☹ ☺ ☺ ☹ ☺ 5/7
Nguyen, 2009
[30].
? ☺ ☹ ☺ ☺ ☹ ☹ 3/7
Nguyen, 2013
[31].
☺ ☺ ☹ ☹ ☺ ☹ ☹ 3/7
Nield, 2012
[32].
☺ ☺ ☹ ☹ ☺ ? ☹ 3/7
Oh, 2003
[33].
? ? ? ? ☹ ? ☹ 0/7
Waterhouse,
2010 [35].
☺ ☺ ☹ ☹ ☹ ☺ ☹ 3/7
☺ Z low risk of bias
? Z unclear risk of bias
☹ Z high risk of bias.
Telehealthcare in COPD 21[30]. The first agreement between assessors in the decision
of risk of bias was 79%. After discussion, the agreement was
96%, and finally, after involving a third author, 100%.
Funding of the included studies are presented in
Appendix D.
Physical activity level
Physical activity level was reported in three studies (Table
1) [29e31]. Duration of endurance exercise measured with
questionnaires [31] and steps/day measured with acceler-
ometer [30] were selected for the meta-analysis. The study
by Garcia-Aymerich et al. [29] was excluded from the meta-
analysis due to a dichotomized scale (yes/no) measuring
physical activity. The study by Nguyen et al. (2009) [30] was
later excluded due to heterogeneity (Table 3), which left
only two groups from the same study [31]. The MD forTable 3 Sensitivity analyses e how exclusion due to heterogen
Before exclusion
SMD/MD 95% CI I2 Numb
Physical activity level 0.081a 0.918 to 0.755 85% 3
Physical capacity 9.2b 2.5 to 21.0 82% 8
Bold numbers indicate a significant result (p < 0.05). Abbreviations
CI Z confidence interval.
a SMD.
b MD.physical activity level was 64.7 min (95% CI, 54.4 to 74.9;
p < 0.001) favoring telehealthcare (Fig. 2). Egger’s test was
not applicable due to few studies.Physical capacity
Physical capacity was reported in eight studies (Table 1)
[27,28,30e35]. The 6-min walk test (6MWT) [27,28,30e34]
was selected for the meta-analysis. The studies by
Nguyen et al. (2013) [31] and Oh et al. [33] were later
excluded due to heterogeneity (Table 3). No difference
between telehealthcare and comparator was found for
6MWT (MD, 1.3 m; 95% CI, 8.1 to 5.5; pZ 0.708) (Fig. 3).
No evidence of publication bias was given by Egger’s test
(p Z 0.813).eity affect the results.
After exclusion
er of groups MD 95% CI I2 Number of groups
64.7 54.4 to 74.9 0% 2
1.3 8.1 to 5.5 14% 5
: SMD Z standardized mean difference; MD Z mean difference;
Figure 2 Forest plot of the effect of telehealthcare on physical activity level. Abbreviations: CZ comparator; CIZ confidence
interval; MD Z mean difference; THC Z telehealthcare.
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Dyspnea was reported in seven studies (Table 1)
[28,29,31e35]. The Chronic Respiratory Questionnaire,
Dyspnea subscale (CRQ-D) [28,31,33e35], Medical Research
Council (MRC) Dyspnea scale [29], and Shortness of Breath
Questionnaire (SOBQ) [32] were selected for the meta-
analysis. No difference between telehealthcare and
comparator was found for dyspnea (SMD, 0.088; 95% CI
0.056 to 0.233; p Z 0.232) (Fig. 4). No evidence of pub-
lication bias was given by Egger’s test (p Z 0.412).
Telehealthcare interventions
In a majority of the studies, the telehealthcare intervention
consisted of regular phone calls with reinforcement, feed-
back and support [27e29,33e35]. As complement to the
phone calls, education about self-management [27,29,33]
and/or exercise training [27,28,33,34] were used. A web-
site was used by patients to report physical activity level,
pulmonary function and symptoms (dyspnea, sputum, signs
of a cold), and to get education and feedback [31].
Reporting was also made via mobile phones with feedback
through short text messages [30]. Both website and mobile
phone interventions were combined with individualized
exercise and self-care plans [30,31]. Live-education using
telehealthcare was carried out through text chats [31] orFigure 3 Forest plot of the effect of telehealthcare on ph
C Z comparator; CI Z confidence interval; MD Z mean differencvideo-calls [32]. The duration of the interventions ranged
from four weeks to 18 months.
The telehealthcare interventions were compared with
ordinary care (optimized medication and ordinary health
care contacts) [27,29,35], exercise training [28,30,34], or
education [31e33]. Some comparators also received tele-
healthcare, although not as the major part of the inter-
vention [34], or without feedback [28,30,31]. Some groups
had received exercise training [28,35] and/or self-
management education [34,35] before baseline
assessment.
Discussion
This systematic review of nine studies, is the first to
investigate the effect of telehealthcare on physical activity
level, physical capacity and dyspnea. The results from the
meta-analysis may imply that telehealthcare have an effect
on physical activity, however this is the results from one
study only and further studies are needed. Despite the
weak support, this is of great importance since physical
activity level is the strongest predictor for mortality in this
group of patients [3]. Telehealthcare did not affect physical
capacity and dyspnea. The results should be interpreted
with caution due to heterogeneity even though. However,
several strategies have been used to decrease the impact of
heterogeneity. Both duration of telehealthcare andysical capacity. Abbreviations: 6MWT Z 6-min walk test;
e; THC Z telehealthcare.
Figure 4 Forest plot of the effect of telehealthcare on dyspnea. Abbreviations: CZ comparator; CIZ confidence interval; CRQ-
DZ chronic respiratory questionnaire, dyspnea subscale; MRCZ Medical Research Council; SMDZ standardized mean difference;
SOBQ Z Shortness of breath questionnaire; THC Z telehealthcare.
Telehealthcare in COPD 23magnitude of comparator intervention were presented in
Figs. 2e4, although no visual pattern of their influence on
the results could be seen.
The comparators did often have similar interventions to
the telehealthcare groups, but without the contact through
phone or internet. This may, of course, contribute to the
small differences between groups in the meta-analysis,
since several studies found within-group changes for the
different outcomes. In addition, Goetzsche et al. [36] note
that when comparing active treatments, even a difference
of 0.1 can be important, since there is relatively small
difference between the treatments. This indicates that
telehealthcare can, in fact, be helpful in making PR more
available, although this requires further studies.
The outcome measures used in the included studies can
be discussed. The 6MWT was the most commonly used
outcome for physical capacity. However, endurance shuttle
walking test (ESWT) has shown better responsiveness than
6MWT regarding physical capacity [37], which might explain
lack of effect. Further, only three studies had measured
physical activity level, one with an objective measure and
two with questionnaires (minutes/week and yes/no,
respectively). Only one of these studies, with two inter-
vention groups, could be included in the final meta-
analysis, which is a major limitation and of course affect
the possibility to draw strong conclusions. Questionnaires
are the easiest way to measure physical activity level,
although both the validity and reliability of this method are
weak. Objective measures, like motion sensors, give a more
accurate information [38,39] and are therefore recom-
mended. These sensors should preferably measure steps
per day or time in light activity, during four weekdays [40].
This meta-analysis showed effect on level of physical ac-
tivity. In systematic reviews evaluating telehealthcare for
other chronic diseases, the effect on physical activity level
varies [41e44]. Increasing physical activity level requires a
change of behavior and there might be a need for more
support for the participants to cope with this. Moreover, for
dyspnea different scales were used, although this was dealtwithin the meta-analysis as the effect measures were
recalculated to SMD.
Other limitations should also be taken into account when
interpreting the results. Many of the included studies were
judged to have a high risk of bias for several domains, which
also reduce the possibility to draw any robust conclusions.
We chose only to include RCTs to decrease the risk of bias.
Even though authors are strongly recommended to register
clinical trials [45,46], most studies lacked this information.
Therefore, we had no opportunity to judge if all pre-
specified outcomes were reported. The most common
cause of high risk of bias was lack of blinding of participants
and personnel, since it is hardly possible to blind partici-
pants, especially when comparing to usual care. The
personnel giving the treatment cannot be blinded at all in
this kind of interventions. This is a lack in Cochrane risk of
bias tool [26], since it is almost impossible to have double-
blinded procedures when performing clinical studies with
exercise or behavioral changing interventions.
In many studies, the telehealthcare intervention was
combined with different variations of education and exer-
cise training. Therefore, it is not possible to determine
what results that were caused by telehealthcare and what
results that was caused by education and exercise training.
To be able to conclude that with certainty more studies
with telehealthcare as the only intervention is needed.
Furthermore, very few studies used the internet to deliver
telehealthcare. Since the use of the internet is constantly
increasing, this may open new paths to reach out with
rehabilitation to patients. Therefore, there is a need for
more studies evaluating telehealthcare, including studies
using the internet as the main intervention, in order to
determine whether telehealthcare can be effective in
increasing physical activity level and physical capacity and
decreasing dyspnea. The studies should be carefully
designed to minimize the risk of bias. To be able to
generalize the results for the whole COPD population and to
see differences between stages of disease severity, tele-
healthcare must be evaluated for patients across the whole
24 S. Lundell et al.span of disease severity. The studies included in this sys-
tematic review only included patients with moderate to
severe COPD. Patients living in remote might be of benefit
of telehealthcare, as well as patients in need to maintain
positive effects after PR, although the effect for these
groups of patients has not been evaluated separately. It is
important that all patients get equal treatment, which
even more highlights the importance of research in the area
of telehealthcare [6].
Conclusion
This is the first systematic review to investigate the effect
of telehealthcare on physical activity level, physical ca-
pacity and dyspnea. Compared to comparators the use of
telehealthcare may lead to increased physical activity
level. No effect on physical capacity and dyspnea was
found. The results should be considered with caution given
the heterogeneity among the studies. Telehealthcare in the
included studies consisted of information, feedback, and
reporting by phone calls, internet or mobile phone in
combination with education and exercise. This is an
important area of research and further studies of the effect
of telehealthcare for patients with COPD are required.
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